Your browser doesn't support javascript.
loading
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.
Denkinger, Claudia M; Janssen, Maike; Schäkel, Ulrike; Gall, Julia; Leo, Albrecht; Stelmach, Patrick; Weber, Stefan F; Krisam, Johannes; Baumann, Lukas; Stermann, Jacek; Merle, Uta; Weigand, Markus A; Nusshag, Christian; Bullinger, Lars; Schrezenmeier, Jens-Florian; Bornhäuser, Martin; Alakel, Nael; Witzke, Oliver; Wolf, Timo; Vehreschild, Maria J G T; Schmiedel, Stefan; Addo, Marylyn M; Herth, Felix; Kreuter, Michael; Tepasse, Phil-Robin; Hertenstein, Bernd; Hänel, Mathias; Morgner, Anke; Kiehl, Michael; Hopfer, Olaf; Wattad, Mohammad-Amen; Schimanski, Carl C; Celik, Cihan; Pohle, Thorsten; Ruhe, Matthias; Kern, Winfried V; Schmitt, Anita; Lorenz, Hanns-Martin; Souto-Carneiro, Margarida; Gaeddert, Mary; Halama, Niels; Meuer, Stefan; Kräusslich, Hans-Georg; Müller, Barbara; Schnitzler, Paul; Parthé, Sylvia; Bartenschlager, Ralf; Gronkowski, Martina; Klemmer, Jennifer; Schmitt, Michael.
Afiliação
  • Denkinger CM; Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany. Claudia.Denkinger@uni-heidelberg.de.
  • Janssen M; Partner site Heidelberg University Hospital, German Center for Infection Research, Heidelberg, Germany. Claudia.Denkinger@uni-heidelberg.de.
  • Schäkel U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Gall J; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Leo A; NCT Trial Center, National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Stelmach P; Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany.
  • Weber SF; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Krisam J; Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Baumann L; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
  • Stermann J; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
  • Merle U; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
  • Weigand MA; Department of Internal Medicine IV, Heidelberg University Hospital, Heidelberg, Germany.
  • Nusshag C; Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Bullinger L; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Schrezenmeier JF; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Bornhäuser M; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Alakel N; Department of Internal Medicine I, University Hospital Dresden and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany.
  • Witzke O; Department of Internal Medicine I, University Hospital Dresden and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany.
  • Wolf T; Department of Infectious Diseases, West German Centre for Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.
  • Schmiedel S; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.
  • Addo MM; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Herth F; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kreuter M; Partner site Hamburg-Lübeck-Borstel-Riems, German Center for Infection Research, Hamburg, Germany.
  • Tepasse PR; University Medical Center Hamburg-Eppendorf, Institute for Infection Research and Vaccine Development, Hamburg, Germany.
  • Hertenstein B; Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany.
  • Hänel M; Center for Interstitial and Rare Lung Diseases, Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany.
  • Morgner A; Department of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, Münster, Germany.
  • Kiehl M; Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany.
  • Hopfer O; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Wattad MA; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Schimanski CC; Department of Internal Medicine I, Frankfurt (Oder) General Hospital, Frankfurt (Oder), Germany.
  • Celik C; Department of Internal Medicine I, Frankfurt (Oder) General Hospital, Frankfurt (Oder), Germany.
  • Pohle T; Department of Hematology, Oncology, Palliative Care and Stem Cell Transplantation, Klinikum Hochsauerland, Meschede, Germany.
  • Ruhe M; Department of Internal Medicine II, Klinikum Darmstadt, Darmstadt, Germany.
  • Kern WV; Department of Internal Medicine II, Klinikum Darmstadt, Darmstadt, Germany.
  • Schmitt A; Department of Internal Medicine I, Klinikum Herford, Herford, Germany.
  • Lorenz HM; Department of Internal Medicine I, Klinikum Herford, Herford, Germany.
  • Souto-Carneiro M; Department of Medicine II, Division of Infectious Diseases and Travel Medicine, University Medical Centre Freiburg, Freiburg, Germany.
  • Gaeddert M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Halama N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Meuer S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Kräusslich HG; Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller B; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Schnitzler P; Department of Translational Immunotherapy (D240), German Cancer Research Center, Heidelberg, Germany.
  • Parthé S; Helmholtz Institute for Translational Oncology, Mainz, Germany.
  • Bartenschlager R; Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany.
  • Gronkowski M; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
  • Klemmer J; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schmitt M; Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Nat Cancer ; 4(1): 96-107, 2023 01.
Article em En | MEDLINE | ID: mdl-36581734
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article